During the past decade, Christus Santa Rosa Hospital conducted 2 clinical trials. In the 10-year time frame, 2 clinical trials started and 1 clinical trials were completed, i.e. on average, 50% percent of trials that started reached the finish line to date. In the past 5 years, 1 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

According to Clinical.Site data, the most researched conditions in "Christus Santa Rosa Hospital" are "Colorectal Adenocarcinomas" (1 trials), "Colorectal Carcinoma" (1 trials), "Esophageal Adenocarcinomas" (1 trials), "Gastric Adenocarcinomas" (1 trials) and "Gastrointestinal Tumors" (1 trials). Many other conditions were trialed in "Christus Santa Rosa Hospital" in a lesser frequency.

Most popular intervention types in "Christus Santa Rosa Hospital" are "Biological" (1 trials), "Device" (1 trials) and "Drug" (1 trials). Other intervention types were less common.

The name of intervention was led by "AdVance Male Sling" (1 trials), "Anti-PD1" (1 trials), "Anti-VEGF" (1 trials), "PF-07062119" (1 trials) and "PF-07209960" (1 trials). Other intervention names were less common.

The vast majority of trials in "Christus Santa Rosa Hospital" are 2 trials for "All" genders and 1 trials for "Male" genders.

Currently, there are NaN active trials in "Christus Santa Rosa Hospital". undefined are not yet recruiting, 1 are recruiting, 1 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 1 completed trials in Christus Santa Rosa Hospital, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Christus Santa Rosa Hospital, 2 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 0 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 1 trials that are defined as “Not Applicable".